Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;6(1):49-54.
doi: 10.1212/CPJ.0000000000000217.

Advances in endovascular therapy for ischemic stroke: A whole new ball game

Affiliations
Review

Advances in endovascular therapy for ischemic stroke: A whole new ball game

Lai Yin Law et al. Neurol Clin Pract. 2016 Feb.

Abstract

Purpose of review: The burden of disability from ischemic stroke continues to intensify. Any acute therapeutic option that reduces disability after ischemic stroke should be encouraged and further studied. In particular, the need for an effective treatment in patients with large vessel occlusion has been long overdue. Recent findings: Consistent trial evidence has answered this need in an emphatic fashion, demonstrating improved functional outcomes with endovascular therapy following better patient selection, new device technology, and reduced treatment times. The article discusses the current evidence and guidelines and highlights the inherent complexities of a specialized intervention whose demand will grow exponentially. The scope for future investigation especially using advanced imaging to expand patient selection will be considered. Summary: Endovascular thrombectomy is an established and highly efficacious acute treatment for ischemic stroke that we need to apply and implement to maximize benefit to the population.

PubMed Disclaimer

References

    1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587. - PubMed
    1. Emberson J, Lees KR, Lyden P, et al.. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929–1935. - PMC - PubMed
    1. Fonarow GC, Zhao X, Smith EE, et al.. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014;311:1632–1640. - PubMed
    1. Bhatia R, Hill MD, Shobha N, et al.. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke real-world experience and a call for action. Stroke 2010;41:2254–2258. - PubMed
    1. Ciccone A, Valvassori L, Nichelatti M, et al.. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368:904–913. - PMC - PubMed

LinkOut - more resources